These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
811 related articles for article (PubMed ID: 31783187)
1. First insights into circulating XDR and pre-XDR Mycobacterium tuberculosis in Southern Brazil. Salvato RS; Costa ERD; Reis AJ; Schiefelbein SH; Halon ML; Barcellos RB; Unis G; Dias CF; Viveiros M; Portugal I; da Silva PEA; Kritski AL; Perdigão J; Rossetti MLR Infect Genet Evol; 2020 Mar; 78():104127. PubMed ID: 31783187 [TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of mutations associated with resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients from high prevalence tuberculosis city in Morocco. Oudghiri A; Karimi H; Chetioui F; Zakham F; Bourkadi JE; Elmessaoudi MD; Laglaoui A; Chaoui I; El Mzibri M BMC Infect Dis; 2018 Feb; 18(1):98. PubMed ID: 29486710 [TBL] [Abstract][Full Text] [Related]
3. Whole-genome sequencing of clinical isolates from tuberculosis patients in India: real-world data indicates a high proportion of pre-XDR cases. Bhanushali A; Atre S; Nair P; Thandaseery GA; Shah S; Kuruwa S; Zade A; Nikam C; Gomare M; Chatterjee A Microbiol Spectr; 2024 May; 12(5):e0277023. PubMed ID: 38597637 [TBL] [Abstract][Full Text] [Related]
4. Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-Natal. Cohen KA; Abeel T; Manson McGuire A; Desjardins CA; Munsamy V; Shea TP; Walker BJ; Bantubani N; Almeida DV; Alvarado L; Chapman SB; Mvelase NR; Duffy EY; Fitzgerald MG; Govender P; Gujja S; Hamilton S; Howarth C; Larimer JD; Maharaj K; Pearson MD; Priest ME; Zeng Q; Padayatchi N; Grosset J; Young SK; Wortman J; Mlisana KP; O'Donnell MR; Birren BW; Bishai WR; Pym AS; Earl AM PLoS Med; 2015 Sep; 12(9):e1001880. PubMed ID: 26418737 [TBL] [Abstract][Full Text] [Related]
5. Genomic-based surveillance reveals high ongoing transmission of multi-drug-resistant Mycobacterium tuberculosis in Southern Brazil. Salvato RS; Reis AJ; Schiefelbein SH; Gómez MAA; Salvato SS; da Silva LV; Costa ERD; Unis G; Dias CF; Viveiros M; Portugal I; von Groll A; da Silva PEA; Kritski AL; Perdigão J; Rossetti MLR Int J Antimicrob Agents; 2021 Oct; 58(4):106401. PubMed ID: 34289403 [TBL] [Abstract][Full Text] [Related]
6. Genetic diversity of Mycobacterium tuberculosis isoniazid monoresistant and multidrug-resistant in Rio Grande do Sul, a tuberculosis high-burden state in Brazil. Esteves LS; Dalla Costa ER; Vasconcellos SEG; Vargas A; Ferreira Junior SLM; Halon ML; Ribeiro MO; Rodenbusch R; Gomes HM; Suffys PN; Rossetti MLR Tuberculosis (Edinb); 2018 May; 110():36-43. PubMed ID: 29779771 [TBL] [Abstract][Full Text] [Related]
7. High fluoroquinolone resistance proportions among multidrug-resistant tuberculosis driven by dominant L2 Mycobacterium tuberculosis clones in the Mumbai Metropolitan Region. Dreyer V; Mandal A; Dev P; Merker M; Barilar I; Utpatel C; Nilgiriwala K; Rodrigues C; Crook DW; ; Rasigade JP; Wirth T; Mistry N; Niemann S Genome Med; 2022 Aug; 14(1):95. PubMed ID: 35989319 [TBL] [Abstract][Full Text] [Related]
8. Frequency of first and second-line drug resistance-associated mutations among resistant Mycobacterium tuberculosis clinical isolates from São Paulo, Brazil. Matsui T; Pinhata JMW; Rabello MCDS; Brandão AP; Ferrazoli L; Leão SC; Viana-Niero C; Oliveira RS Mem Inst Oswaldo Cruz; 2020; 115():e200055. PubMed ID: 32401997 [TBL] [Abstract][Full Text] [Related]
9. Genotyping and clinical characteristics of multidrug and extensively drug-resistant tuberculosis in a tertiary care tuberculosis hospital in China. Yuan X; Zhang T; Kawakami K; Zhu J; Zheng W; Li H; Deng G; Tu S; Liu W BMC Infect Dis; 2013 Jul; 13():315. PubMed ID: 23849244 [TBL] [Abstract][Full Text] [Related]
10. Whole genome sequencing analysis of Mycobacterium tuberculosis reveals circulating strain types and drug-resistance mutations in the Philippines. Wang L; Lim DR; Phelan JE; Reyes LT; Palparan AG; Sanchez MGC; Asuncion LAA; Tujan MAA; Medado IAP; Daga CMA; Llames JS; Mitarai S; Murase Y; Morishige Y; Ang CF; Malabad JCM; Montoya JC; Hafalla JC; Campino S; Hibberd ML; Ama CG; Basilio RP; La Paz EMC; Clark TG Sci Rep; 2024 Aug; 14(1):19602. PubMed ID: 39179783 [TBL] [Abstract][Full Text] [Related]
11. Whole genome sequencing of drug resistant Mycobacterium tuberculosis isolates from a high burden tuberculosis region of North West Pakistan. Jabbar A; Phelan JE; de Sessions PF; Khan TA; Rahman H; Khan SN; Cantillon DM; Wildner LM; Ali S; Campino S; Waddell SJ; Clark TG Sci Rep; 2019 Oct; 9(1):14996. PubMed ID: 31628383 [TBL] [Abstract][Full Text] [Related]
12. Drug-resistant Mycobacterium tuberculosis among Nepalese patients at a tuberculosis referral center. Chand AB; Basnet A; Maharjan B; Rai G; Joshi YP; Bhatt LR; Sen B; Rai SK PLoS One; 2024; 19(5):e0301210. PubMed ID: 38709710 [TBL] [Abstract][Full Text] [Related]
13. Molecular characterization of multidrug-resistant Mycobacterium tuberculosis isolates from high prevalence tuberculosis states in Mexico. Juarez-Eusebio DM; Munro-Rojas D; Muñiz-Salazar R; Laniado-Laborín R; Martinez-Guarneros JA; Flores-López CA; Zenteno-Cuevas R Infect Genet Evol; 2017 Nov; 55():384-391. PubMed ID: 27637930 [TBL] [Abstract][Full Text] [Related]
14. Early detection of multidrug- and pre-extensively drug-resistant tuberculosis from smear-positive sputum by direct sequencing. Chen J; Peng P; Du Y; Ren Y; Chen L; Rao Y; Wang W BMC Infect Dis; 2017 Apr; 17(1):300. PubMed ID: 28438132 [TBL] [Abstract][Full Text] [Related]
15. Surveillance and characterization of drug-resistant Imperiale BR; Di Giulio ÁB; Mancino MB; Zumárraga MJ; Morcillo NS Int J Mycobacteriol; 2019; 8(3):223-228. PubMed ID: 31512597 [TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of multidrug-resistant Mycobacterium tuberculosis (MDR-TB) isolates identifies local transmission of infection in Kuwait, a country with a low incidence of TB and MDR-TB. Al-Mutairi NM; Ahmad S; Mokaddas EM Eur J Med Res; 2019 Dec; 24(1):38. PubMed ID: 31806020 [TBL] [Abstract][Full Text] [Related]
17. Prevalence and molecular characteristics of drug-resistant Mycobacterium tuberculosis in Beijing, China: 2006 versus 2012. Yin QQ; Jiao WW; Li QJ; Xu F; Li JQ; Sun L; Li YJ; Huang HR; Shen AD BMC Microbiol; 2016 May; 16():85. PubMed ID: 27176471 [TBL] [Abstract][Full Text] [Related]
18. Mycobacterial interspersed repetitive unit typing and mutational profile for multidrug-resistant and extensively drug-resistant tuberculosis surveillance in Portugal: a 3-year period overview. Silva C; Perdigão J; Jordão L; Portugal I Int J Antimicrob Agents; 2014 Dec; 44(6):546-51. PubMed ID: 25270633 [TBL] [Abstract][Full Text] [Related]
19. Redefining MDR-TB: Comparison of Mycobacterium tuberculosis clinical isolates from Russia and Taiwan. Jou R; Lee WT; Kulagina EV; Weng JY; Isakova AI; Lin WH; Antonova OV; Wu MH; Arslanbaeva LR; Tasi HY; Nosova EY; Zimenkov DV Infect Genet Evol; 2019 Aug; 72():141-146. PubMed ID: 30593924 [TBL] [Abstract][Full Text] [Related]
20. Use of whole-genome sequencing to predict Mycobacterium tuberculosis drug resistance in Indonesia. Chaidir L; Ruesen C; Dutilh BE; Ganiem AR; Andryani A; Apriani L; Huynen MA; Ruslami R; Hill PC; van Crevel R; Alisjahbana B J Glob Antimicrob Resist; 2019 Mar; 16():170-177. PubMed ID: 30172045 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]